JP2022530443A5 - - Google Patents

Info

Publication number
JP2022530443A5
JP2022530443A5 JP2021563172A JP2021563172A JP2022530443A5 JP 2022530443 A5 JP2022530443 A5 JP 2022530443A5 JP 2021563172 A JP2021563172 A JP 2021563172A JP 2021563172 A JP2021563172 A JP 2021563172A JP 2022530443 A5 JP2022530443 A5 JP 2022530443A5
Authority
JP
Japan
Prior art keywords
antibody
seq
amino acid
antigen
variable region
Prior art date
Application number
JP2021563172A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020219778A5 (https=
JP2022530443A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029664 external-priority patent/WO2020219778A2/en
Publication of JP2022530443A publication Critical patent/JP2022530443A/ja
Publication of JPWO2020219778A5 publication Critical patent/JPWO2020219778A5/ja
Publication of JP2022530443A5 publication Critical patent/JP2022530443A5/ja
Withdrawn legal-status Critical Current

Links

JP2021563172A 2019-04-24 2020-04-23 抗ｃｄ１１７抗体薬物複合体およびその使用 Withdrawn JP2022530443A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962838286P 2019-04-24 2019-04-24
US62/838,286 2019-04-24
PCT/US2020/029664 WO2020219778A2 (en) 2019-04-24 2020-04-23 Anti-cd117 antibody-drug conjugates and uses thereof

Publications (3)

Publication Number Publication Date
JP2022530443A JP2022530443A (ja) 2022-06-29
JPWO2020219778A5 JPWO2020219778A5 (https=) 2022-08-23
JP2022530443A5 true JP2022530443A5 (https=) 2022-08-23

Family

ID=72940692

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021563172A Withdrawn JP2022530443A (ja) 2019-04-24 2020-04-23 抗ｃｄ１１７抗体薬物複合体およびその使用

Country Status (4)

Country Link
US (1) US20220177577A1 (https=)
EP (1) EP3958899A4 (https=)
JP (1) JP2022530443A (https=)
WO (1) WO2020219778A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3079215A1 (en) 2017-10-24 2019-05-02 Magenta Therapeutics, Inc. Compositions and methods for the depletion of cd117+ cells
CN121555430A (zh) 2018-05-11 2026-02-24 比姆医疗股份有限公司 使用可编程碱基编辑器系统取代病原性氨基酸的方法
CN113330026A (zh) * 2018-10-23 2021-08-31 美真达治疗公司 Fc沉默的抗体药物缀合物(ADC)及其用途
CN113993550A (zh) * 2019-04-24 2022-01-28 美真达治疗公司 用于基因疗法的调理方法
EP3959242A4 (en) * 2019-04-24 2023-09-13 Magenta Therapeutics, Inc. ANTRACYCLINE ANTIBODY-DRUG CONJUGATES AND THEIR USES

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2613841T3 (es) * 2008-07-16 2017-05-26 Medical And Biological Laboratories Co., Ltd. Anticuerpo anti-CLCP1 humano y uso del mismo
CN116574185A (zh) * 2012-07-25 2023-08-11 塞尔德克斯医疗公司 抗kit抗体及其用途
EP3370768B9 (en) * 2015-11-03 2022-03-16 Janssen Biotech, Inc. Antibodies specifically binding pd-1 and their uses
BR112018076306A2 (pt) * 2016-06-17 2019-03-26 Magenta Therapeutics, Inc. composições e métodos para a supressão de células cd117+
CA3079215A1 (en) * 2017-10-24 2019-05-02 Magenta Therapeutics, Inc. Compositions and methods for the depletion of cd117+ cells
WO2019084067A1 (en) * 2017-10-24 2019-05-02 Magenta Therapeutics, Inc. ANTI-CD117 ANTIBODIES AND METHODS OF USE
CA3079897A1 (en) * 2017-10-24 2019-05-02 Magenta Therapeutics, Inc. Compositions and methods for the depletion of cd117+ cells
WO2019234694A2 (en) * 2018-06-07 2019-12-12 Magenta Therapeutics, Inc. Therapeutic methods using antibody drug conjugates (adcs)
CN113330026A (zh) * 2018-10-23 2021-08-31 美真达治疗公司 Fc沉默的抗体药物缀合物(ADC)及其用途
JP2022512781A (ja) * 2018-10-30 2022-02-07 マジェンタ セラピューティクス インコーポレイテッド 同種造血幹細胞移植の方法

Similar Documents

Publication Publication Date Title
JP7650819B2 (ja) 抗－ｃｄ４５抗体薬物コンジュゲート及びその使用
JP7709376B2 (ja) Ｆｃサイレンス化抗体薬物コンジュゲート（ＡＤＣ）及びその使用
JP7669269B2 (ja) 抗－ｃｄ４５抗体及びそのコンジュゲート
JP2025060760A (ja) アマトキシン抗体薬物複合体及びその使用
TWI904109B (zh) 抗ｃｄ４５抗體及其結合物
US20220175944A1 (en) Anti-cd117 antibody-drug conjugates and uses thereof
JP2021500375A5 (https=)
JP2021504412A (ja) Ｃｄ５＋細胞の枯渇のための組成物および方法
JP2022530443A5 (https=)
JPWO2020219959A5 (https=)
JP2022529726A5 (https=)
US20220177577A1 (en) Anti-cd117 antibody drug conjugates and uses thereof
US20220226493A1 (en) Anthracycline antibody-drug conjugates and uses thereof
JPWO2020092654A5 (https=)
JP2025172753A (ja) 自己免疫疾患を治療するための方法および組成物
JP2022529727A5 (https=)
JPWO2020219775A5 (https=)
JPWO2020219778A5 (https=)
JPWO2020219774A5 (https=)
JP2021517133A (ja) 抗ｃｄ２５２抗体、コンジュゲート、および使用方法
JPWO2020219748A5 (https=)